MCID: TKY002
MIFTS: 60

Takayasu Arteritis malady

Categories: Rare diseases, Cardiovascular diseases, Nephrological diseases, Bone diseases

Aliases & Classifications for Takayasu Arteritis

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 32ICD9CM, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 52OMIM, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Takayasu Arteritis:

Name: Takayasu Arteritis 52 11 48 54 39 68
Aortic Arch Syndromes 39 68
Takayasu's Arteritis 11 13
Aortic Arch Syndrome 11 48
Idiopathic Aortitis 11 68
Young Female Arteritis 48
 
Aortic Arch Arteritis 11
Aortic Arches Defect 48
Takayasu's Disease 11
Pulseless Disease 48
Takayasu Disease 48
Ta 48

Characteristics:

Orphanet epidemiological data:

54
takayasu arteritis:
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe),<1/1000000 (United Kingdom),1-9/100000 (Japan),1-9/1000000 (Sweden),1-9/1000000 (United Kingdom); Age of onset: Adolescent,Adult; Age of death: adult

Classifications:



External Ids:

OMIM52 207600
Disease Ontology11 DOID:2508
ICD1030 M31.4
ICD9CM32 446.7
Orphanet54 ORPHA3287
UMLS via Orphanet69 C0039263
ICD10 via Orphanet31 M31.4
MESH via Orphanet40 D013625

Summaries for Takayasu Arteritis

About this section
NIH Rare Diseases:48 Takayasu arteritis is a condition that causes inflammation of the main blood vessel that carries blood from the heart to the rest of the body (aorta) and its associated branched blood vessels. As a result of the inflammation, the blood vessel walls become thick and make it difficult for blood to flow. Over time, impaired blood flow causes damage to the heart and various other organs of the body.  Although the cause remains unknown, Takayasu arteritis appears to be an autoimmune condition, in which cells that fight infection and disease are wrongly targeted against the body's own tissues. Last updated: 11/3/2013

MalaCards based summary: Takayasu Arteritis, also known as aortic arch syndromes, is related to common variable immunodeficiency and renovascular hypertension, and has symptoms including hyperhidrosis, weight loss and aneurysm. An important gene associated with Takayasu Arteritis is HLA-B (Major Histocompatibility Complex, Class I, B), and among its related pathways are Pertussis and Legionellosis. The drug alprostadil has been mentioned in the context of this disorder. Affiliated tissues include heart, t cells and skin, and related mouse phenotypes are Increased shRNA abundance (Z-score > 2) and digestive/alimentary.

Disease Ontology:11 A syndrome that involves inflammation of the aorta that carries blood from the heart to the rest of the body.

Description from OMIM:52 207600

Related Diseases for Takayasu Arteritis

About this section

Diseases related to Takayasu Arteritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 372)
idRelated DiseaseScoreTop Affiliating Genes
1common variable immunodeficiency30.8HLA-B, HLA-DRB1, TNF
2renovascular hypertension30.3CD40LG, HLA-DRB1, IL2, TNF
3pyoderma gangrenosum30.1IL2, IL6, TNF
4myocardial infarction28.0CRP, ICAM1, IL6, MMP3, MMP9, PON1
5systemic lupus erythematosus27.4CD40LG, CRP, HLA-DPB1, HLA-DRB1, ICAM1, IL2
6atypical coarctation of aorta11.1
7cervical aortic arch11.1
8rhizomelic dysplasia, scoliosis, and retinitis pigmentosa10.8MMP3, MMP9
9panner disease10.7CRP, IL6, TNF
10hernia of ovary and fallopian tube10.7HLA-B, HLA-DRB1, TNF
11abdominal chemodectomas with cutaneous angiolipomas10.7HLA-DRB1, IL6, TNF
12lymphocytic colitis10.7HLA-DRB1, IL6, TNF
13aneurysm of sinus of valsalva10.7CRP, IL6
14islet cell tumor10.7CRP, IL6, TNF
15mastocytosis cutaneous with short stature conductive hearing loss and microtia10.7HLA-DRB1, IL6, TNF
16paraneoplastic polyneuropathy10.7CRP, IL6, TNF
17corneal intraepithelial neoplasm10.7HLA-B, IL6, TNF
18mechanical lagophthalmos10.7CRP, IL6, TNF
19oral candidiasis10.7CRP, IL6, TNF
20keloids10.6IL6, MMP3, TNF
21large cell carcinoma with rhabdoid phenotype10.6CRP, MMP9, TNF
22cervix erosion10.6CRP, IL6, TNF
23c1 inhibitor deficiency10.6CRP, IL6, TNF
24linitis plastica10.6IL2, TNF
25bardet-biedl syndrome 810.6CRP, IL6, TNF
26benign peritoneal mesothelioma10.6CRP, IL6, TNF
27cutaneous porphyria10.6CRP, IL6, TNF
28ampulla of vater neoplasm10.6IL6, SELE, TNF
29spondylolysis10.6CRP, IL6, TNF
30actinomycosis10.6IL6, SELE, TNF
31gonococcal synovitis10.6MMP9, SELE, TNF
32diphtheria10.6CRP, IL6, TNF
33extrahepatic cholestasis10.6CRP, IL6, TNF
34orbital lymphangioma10.6IL6, TNF, VCAM1
35elejalde disease10.6HLA-DRB1, MMP3, SELE
36burn scar10.6IL6, MMP9, TNF
37nervous system cancer10.6IL6, MMP9, TNF
38branch retinal artery occlusion10.6HLA-A, HLA-B
39vertebral artery occlusion10.6IL6, MMP3, MMP9
40maligant granulosa cell tumor of ovary10.6IL2, IL6, TNF
41vitreoretinochoroidopathy dominant10.6HLA-B, HLA-DRB1, IL2
42mononeuritis of lower limb10.6CRP, MMP9, TNF
43mandibular cancer10.6CRP, IL6, TNF
44splenic manifestation of prolymphocytic leukemia10.6IL2, IL6, TNF
45tracheal calcification10.6CRP, IL6, TNF
46heart septal defect10.6CRP, IL6, TNF
47spinal stenosis10.6IL6, MMP9, TNF
48aortic arch interruption10.6IL6, TNF
49midline interhemispheric variant of holoprosencephaly10.6CRP, IL2, IL6
50short bowel syndrome10.6CRP, IL6, TNF

Graphical network of the top 20 diseases related to Takayasu Arteritis:



Diseases related to takayasu arteritis

Symptoms & Phenotypes for Takayasu Arteritis

About this section

Symptoms by clinical synopsis from OMIM:

207600

Clinical features from OMIM:

207600

Human phenotypes related to Takayasu Arteritis:

 64 54 (show all 48)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hyperhidrosis64 54 hallmark (90%) Very frequent (99-80%) HP:0000975
2 weight loss64 54 hallmark (90%) Very frequent (99-80%) HP:0001824
3 aneurysm64 54 hallmark (90%) Very frequent (99-80%) HP:0002617
4 vasculitis64 54 hallmark (90%) Very frequent (99-80%) HP:0002633
5 abnormality of temperature regulation64 hallmark (90%) HP:0004370
6 hypertensive crisis64 54 hallmark (90%) Very frequent (99-80%) HP:0100735
7 abnormality of the aorta64 hallmark (90%) HP:0001679
8 visual impairment64 typical (50%) HP:0000505
9 seizures64 54 typical (50%) Frequent (79-30%) HP:0001250
10 muscle weakness64 54 typical (50%) Frequent (79-30%) HP:0001324
11 arthritis64 54 typical (50%) Frequent (79-30%) HP:0001369
12 hypertrophic cardiomyopathy64 54 typical (50%) Frequent (79-30%) HP:0001639
13 abnormality of the aortic valve64 54 typical (50%) Frequent (79-30%) HP:0001646
14 coronary artery disease64 typical (50%) HP:0001677
15 anemia64 54 typical (50%) Frequent (79-30%) HP:0001903
16 anorexia64 54 typical (50%) Frequent (79-30%) HP:0002039
17 migraine64 54 typical (50%) Frequent (79-30%) HP:0002076
18 pulmonary hypertension64 54 typical (50%) Frequent (79-30%) HP:0002092
19 abnormal pattern of respiration64 54 typical (50%) Frequent (79-30%) HP:0002793
20 myalgia64 54 typical (50%) Frequent (79-30%) HP:0003326
21 dilatation of the ascending aorta64 54 typical (50%) Frequent (79-30%) HP:0005111
22 inflammatory abnormality of the eye64 54 typical (50%) Frequent (79-30%) HP:0100533
23 chest pain64 54 typical (50%) Frequent (79-30%) HP:0100749
24 gangrene64 54 typical (50%) Frequent (79-30%) HP:0100758
25 skin ulcer64 54 typical (50%) Frequent (79-30%) HP:0200042
26 respiratory insufficiency64 typical (50%) HP:0002093
27 apnea64 typical (50%) HP:0002104
28 retinopathy64 54 occasional (7.5%) Occasional (29-5%) HP:0000488
29 hemoptysis64 54 occasional (7.5%) Occasional (29-5%) HP:0002105
30 neurological speech impairment64 54 occasional (7.5%) Occasional (29-5%) HP:0002167
31 cerebral ischemia64 54 occasional (7.5%) Occasional (29-5%) HP:0002637
32 arthralgia64 54 occasional (7.5%) Occasional (29-5%) HP:0002829
33 abnormality of the endocardium64 54 occasional (7.5%) Occasional (29-5%) HP:0004306
34 reduced consciousness/confusion64 54 occasional (7.5%) Occasional (29-5%) HP:0004372
35 gastrointestinal infarctions64 54 occasional (7.5%) Occasional (29-5%) HP:0005244
36 amaurosis fugax64 54 occasional (7.5%) Occasional (29-5%) HP:0100576
37 asthma64 occasional (7.5%) HP:0002099
38 recurrent respiratory infections64 occasional (7.5%) HP:0002205
39 feeding difficulties in infancy64 occasional (7.5%) HP:0008872
40 arteritis64 HP:0012089
41 hypertension54 Frequent (79-30%)
42 subcutaneous nodule54 Very frequent (99-80%)
43 abnormality of the heart valves54 Very frequent (99-80%)
44 myocardial infarction54 Frequent (79-30%)
45 fever54 Very frequent (99-80%)
46 fatigue54 Very frequent (99-80%)
47 increased inflammatory response54 Frequent (79-30%)
48 arterial stenosis54 Very frequent (99-80%)

UMLS symptoms related to Takayasu Arteritis:


vasculitic rash

GenomeRNAi Phenotypes related to Takayasu Arteritis according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-359.5HLA-A, HLA-B, MICA, SELE

MGI Mouse Phenotypes related to Takayasu Arteritis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053817.5ICAM1, IL12B, IL2, IL6, MMP9, THBD
2MP:00053846.3CD40LG, ICAM1, IL2, IL6, MMP9, PON1
3MP:00053976.3CD40LG, ICAM1, IL12B, IL2, IL6, MMP3
4MP:00053876.1CD40LG, CRP, ICAM1, IL12B, IL2, IL6
5MP:00053856.0CD40LG, CRP, ICAM1, IL2, IL6, MMP9
6MP:00053765.5CD40LG, CRP, ICAM1, IL12B, IL2, IL6

Drugs & Therapeutics for Takayasu Arteritis

About this section

Drugs for Takayasu Arteritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 63)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Omega 3 Fatty AcidNutraceuticalPhase 4969
2ImmunoglobulinsPhase 36045
3AntibodiesPhase 36045
4
Prednisoneapproved, vet_approvedPhase 2135953-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
5
AbataceptapprovedPhase 2192332348-12-610237
Synonyms:
CTLA4-Ig
 
CTLA4-IgG4m
CTLA4Ig
CTLA4IgG4m
6
InfliximabapprovedPhase 2378170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
7
AldesleukinapprovedPhase 239785898-30-2, 110942-02-4
Synonyms:
125-L-serine-2-133-interleukin 2 (human reduced)
 
Interleukin-2 aldesleukin
Interleukin-2(2-133),125-ser
Recombinant interleukin-2 human
8Peripheral Nervous System AgentsPhase 222776
9Antirheumatic AgentsPhase 210627
10Gastrointestinal AgentsPhase 28109
11glucocorticoidsPhase 24920
12Dermatologic AgentsPhase 25674
13Immunosuppressive AgentsPhase 212770
14Interleukin-2Phase 2553
15AnalgesicsPhase 211287
16Analgesics, Non-NarcoticPhase 26260
17HematinicsPhase 1, Phase 21630
18Epoetin alfaPhase 1, Phase 2645113427-24-0
19
Cyclosporineapproved, investigational, vet_approved91579217-60-0, 59865-13-35284373, 6435893
Synonyms:
1c5f
1cyn
30024_FLUKA
30024_SIGMA
59865-13-3
79217-60-0
AC1L1EQW
AC1NQXJE
AC1NR4C4
AC1NUQK3
AC1NUZNC
AC1O5KOG
AC1Q2UDG
Ambap59865-13-3
Ambotz59865-13-3
Antibiotic S 7481F1
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
BPBio1_000496
BRD-A64290322-001-01-6
BRD-A69815203-001-04-3
BRD-K13533483-001-03-0
BSPBio_000450
BSPBio_001596
BSPBio_003186
C 3662
C05086
C1832_SIGMA
C3662_SIGMA
C62H111N11O12
CB-01-09 MMX
CHEBI:106343
CHEBI:328305
CHEBI:4031
CHEMBL160
CHEMBL386389
CHEMBL532318
CID2909
CID5280754
CID5284373
CID5458585
CID5497195
CID6435893
CSA
CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A))
CYCLOSPORIN A, USP
Ciclosporin
Ciclosporin (JP15)
Ciclosporina
Ciclosporine
Ciclosporinum
Cipol N
Cipol-N
Consupren
Consupren S
CsA
CsA & IFN.alpha.
CyA
Cyclokat
Cyclosporin
Cyclosporin A
Cyclosporin A & IFN.alpha.
Cyclosporin A Implant
Cyclosporin A, Tolypocladium inflatum
Cyclosporine (USP)
Cyclosporine A
Cyclosporine [USAN]
D00184
DE-076
DivK1c_000871
EU-0100242
Equoral
GNF-Pf-2808
Gengraf
Gengraf (TN)
HMS1569G12
HMS1791P18
HMS1921L20
HMS1989P18
HMS2089A09
HMS2092F06
HMS502L13
Helv Chim Acta 60: 1568 (1977)
 
I06-0379
I06-0966
IDI1_000871
KBio1_000871
KBio2_000780
KBio2_003348
KBio2_005916
KBio3_002686
KBioGR_001898
KBioSS_000780
LMPK14000003
LS-257
LS-58836
Lopac0_000242
MLS000028376
MLS001333756
MLS002153454
MLS002207033
Mitogard
Modusik-A
MolPort-000-760-988
MolPort-005-934-008
MolPort-006-705-994
NCGC00093704-01
NCGC00093704-02
NCGC00093704-03
NCGC00093704-04
NCGC00093704-05
NCGC00093704-06
NCGC00093704-07
NCGC00093704-08
NCGC00164258-01
NCGC00164258-02
NINDS_000871
NSC290193
Neoplanta
Neoral
Neoral (TN)
NeuroSTAT
Nova-22007
OL 27-400
OL-27400
OLO-400
Papilock
Prestwick2_000435
Prestwick3_000435
Prestwick_731
Pulminiq
Ramihyphin A
Restasis
Restasis (TN)
S-Neoral
S1514_Selleck
SDZ-OXL 400
SMR000058578
SPBio_001467
SPECTRUM1502202
ST-603
Sandimmun
Sandimmun Neoral
Sandimmune
Sandimmune (TN)
Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine
Sang-2000
Sang-35
SangCyA
Sangcya
Sigmasporin
Sigmasporin Microoral
Spectrum2_001484
Spectrum3_001593
Spectrum4_001279
Spectrum5_001628
Spectrum_000300
TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)
Vekacia
Zyclorin
cyclophorine
cyclosporin A
cyclosporine
from Tolypocladium inflatum (Trichoderma polysporin)
nchembio.184-comp6
nchembio.301-comp5
nchembio.342-comp1
20
Lenograstimapproved1202135968-09-1
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
 
Granulocyte colony stimulating factor 3 (CHO cell derived)
Granulocyte colony-stimulating factor lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
21
Miconazoleapproved, investigational, vet_approved362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
22
Methylprednisoloneapproved, vet_approved115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
23
Cyclophosphamideapproved, investigational282950-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
24
Prednisoloneapproved, vet_approved115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
25
Fludarabineapproved111321679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ARAA
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-fluoro ARA-A
21679-14-1
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
Fludara, Fludarabine
 
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
26
Clofarabineapproved, investigational157123318-82-1119182
Synonyms:
(2R,3R,4S,5R)-5-(6-amino-2-Chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
123318-82-1
2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine
2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
2-Cl-2'-F-araA
2-chloro-9-(2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine
2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine
2-chloro-9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
3S211048
AC-274
AC1L3OC8
AKOS005063562
Bio-0121
C1-F-Ara-A
CAFdA
CFB
CHEBI:681569
CHEMBL1750
CID119182
CL-F-Ara-a
 
Cl-F-Ara-A
Clofarabin
Clofarabina
Clofarabine
Clofarabine (USAN/INN)
Clofarabine [USAN]
Clofarabinum
Clofarex
Clolar
Clolar (TN)
Clolar, Evoltra, Clofarabine
D03546
DB00631
DB07554
Evoltra
FT-0082882
HMS2090A07
LS-126466
MolPort-005-941-711
S1218_Selleck
UNII-762RDY0Y2H
ZINC03798247
clofarabina
clofarabinum
27
Vidarabineapproved51224356-66-932326, 21704
Synonyms:
(+)-Cyclaradine
.beta.-Adenosine
.beta.-D-Adenosine
1odi
2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
2946-52-3
2fqy
2gl0
30143-02-3
3080-29-3
3228-71-5
4005-33-8
46946-45-6
46969-16-8
524-69-6
5536-17-4
58-61-7
9-Arabinosyladenine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl-adenine
9-β-D-arabinofuranosyl-9H-purin-6-amine
9-β-D-arabinofuranosyladenine
A 9251
A0152
A4036_SIGMA
A4676_SIGMA
A5762_SIGMA
A9251_SIGMA
AC1L18OL
AC1L1U8O
AC1L2IWM
AC1L2SCM
AC1O4WIN
AC1O8PY7
AC1Q1ID3
AC1Q4Y1Z
AC1Q52XU
ADENOSINE, U.S.P.
ADN
AI3-52413
AI3-52821
AR-1H6029
ARA-A NSC 247519
Ade-Rib
Adenine Arabinoside
Adenine arabinoside
Adenine nucleoside
Adenine riboside
Adenine xyloside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine arabinose
Adenosine-8-14C
Adensoine
Ambap5536-17-4
Ara A
Ara-A
Ara-ATP
Araadenosine
Arabinoside Adenine
Arabinoside adenine
Arabinosyl Adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
BB_NC-0565
BPBio1_000898
BRN 0624881
BSPBio_000816
BSPBio_001796
BSPBio_002000
Bio1_000437
Bio1_000926
Bio1_001415
Boniton
C00212
CAS-5536-17-4
CCRIS 2557
CCRIS 3383
CHEBI:136932
CHEBI:16335
CHEBI:45327
CHEMBL1090
CHEMBL20247
CHEMBL477
CI 673
CI-673
CID102198
CID191
CID21704
CID60961
CID6420052
CID6713976
CPD000471872
Caswell No. 010B
D000241
D00045
D06298
DB00640
DivK1c_000191
EINECS 200-389-9
EINECS 217-911-6
EINECS 226-893-9
EU-0100123
FT-0082881
HMS1570I18
HMS1920A13
HMS1921K05
HMS2090F06
HMS2091G13
HMS2092C16
HMS500J13
HSDB 6514
 
I01-1121
IDI1_000191
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001296
KBio3_001500
KBioGR_001224
KBioSS_002424
L000094
LS-15059
LS-15085
Lopac0_000123
MEDR-640
MLS000069638
MLS000699527
MLS001066352
MLS001333133
MLS001333134
MLS002153227
MLS002153992
MolPort-001-785-903
MolPort-001-838-229
MolPort-003-666-308
Myocol
NCGC00016656-01
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NCGC00094579-01
NCGC00094579-02
NCGC00094579-03
NCGC00094579-04
NCGC00178869-01
NCGC00179417-01
NCI60_003823
NCI60_037192
NCIOpen2_003303
NCIOpen2_005376
NINDS_000191
NSC 247519
NSC 404241
NSC 627048
NSC 7359
NSC 7652
NSC-404241
NSC247519
NSC404241
NSC627048
NSC70422
NSC7359
NSC7652
NSC80832
NSC87676
NSC91041
Nucleocardyl
PDSP1_001036
PDSP2_001020
Pallacor
Polyadenosine
Polyriboadenosine
Prestwick0_000768
Prestwick1_000768
Prestwick2_000768
Prestwick3_000768
Prestwick_983
RAB
S1647_Selleck
S1784_Selleck
SAM002564191
SMP1_000312
SMR000058216
SMR000225041
SMR000471872
SMR001233326
SPBio_001194
SPBio_001491
SPBio_002755
SPECTRUM1500107
SPECTRUM1500609
SR 96225
SR-96225
STK361815
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum2_001336
Spectrum3_000288
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spectrum_001894
Spongoadenosine
TL8003749
UNII-3XQD2MEW34
UNII-K72T3FS567
USAF CB-10
V0098
VIRDARABINE
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine
Vidarabine (JAN)
Vidarabine anhydrous
Vidarabinum
Vira ATM
Vira-A
Vira-A, Vidarabine
XA
Xylosyl A
Xylosyladenine
ZINC00970363
ZINC02169830
adenine-D-ribose
adenosine
alpha-Ara A
beta-Adenosine
beta-Ara A
beta-D-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.64-comp4
nchembio706-5
28
Leflunomideapproved, investigational6775706-12-63899
Synonyms:
210165-51-8
4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl
4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide
5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
75706-12-6
A77 1486
AB00052389
AC-6796
AC1L1GYK
AC1Q2EVA
AKOS000265193
AP-501/42475599
Arava
Arava (TN)
Arava, Leflunomide
Aventis Behring Brand of Leflunomide
Aventis Brand of Leflunomide
Aventis Pharma Brand of Leflunomide
BIDD:PXR0189
BPBio1_000930
BRD-K78692225-001-03-9
BSPBio_000844
C045463
C07905
CAS-75706-12-6
CHEBI:6402
CHEMBL960
CID3899
D00749
DB01097
DivK1c_000916
EU-0100649
HMS1570K06
HMS1922M06
HMS2090O12
HMS502N18
HSDB 7289
HWA 486
HWA-486
Hoechst Brand of Leflunomide
I06-2131
IDI1_000916
KBio1_000916
KBio2_000802
KBio2_003370
KBio2_005938
KBioSS_000802
L 5025
L5025_SIGMA
 
LS-86580
Leflunomid
Leflunomida
Leflunomida [INN-Spanish]
Leflunomide
Leflunomide (JAN/USAN/INN)
Leflunomide [USAN:INN]
Leflunomidum
Leflunomidum [INN-Latin]
Lefunomide
Lefunomide [INN-Spanish]
Lefunomide [Inn-Spanish]
Lopac-L-5025
Lopac0_000649
MLS-0003109.0001
MLS000069648
MLS001076267
MolPort-002-345-613
N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
NCGC00015610-01
NCGC00015610-02
NCGC00015610-03
NCGC00015610-07
NCGC00015610-12
NCGC00022625-03
NCGC00022625-04
NCGC00022625-05
NCGC00022625-06
NCGC00022625-07
NCGC00022625-08
NINDS_000916
NSC677411
Prestwick0_000772
Prestwick1_000772
Prestwick2_000772
Prestwick3_000772
Prestwick_87
RS-34821
S1247_Selleck
SMR000058209
SPBio_002783
SPECTRUM1503927
SU 101
SU 101 (pharmaceutical)
SU-101
SU101
Spectrum5_000850
Spectrum_000322
TL8005179
UNII-G162GK9U4W
ZINC00004840
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
leflunomide
lefunamide
29
Benzocaineapproved18921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
30
Glucosamineapproved, Nutraceutical1823416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
31tannic acidapproved, Nutraceutical1892
32Neuroprotective Agents1672
33Prednisolone phosphate1153
34Protective Agents7190
35Prednisolone hemisuccinate1153
36Prednisolone acetate1153
37Hormones13979
38Antifungal Agents3615
39Antiemetics3888
40Antineoplastic Agents, Alkylating4474
41Anti-Infective Agents21402
42Anti-Inflammatory Agents10355
43Methylprednisolone Hemisuccinate1153
44Alkylating Agents4694
45Antineoplastic Agents, Hormonal5407
46Hormones, Hormone Substitutes, and Hormone Antagonists12767
47Methylprednisolone acetate1153
48Hormone Antagonists12778
49Calcineurin Inhibitors1597
50Autonomic Agents9774

Interventional clinical trials:

(show all 31)
idNameStatusNCT IDPhase
1Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein LevelsTerminatedNCT00578578Phase 4
2Efficacy and Tolerance of Tocilizumab In Takayasu ArteritisUnknown statusNCT02101333Phase 3
3Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's ArteritisCompletedNCT00556439Phase 2
4Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu ArteritisRecruitingNCT02457585Phase 2
5Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesRecruitingNCT01988506Phase 2
6Erythropoetin Neuroprotection for Neonatal Cardiac SurgeryActive, not recruitingNCT00513240Phase 1, Phase 2
7Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesUnknown statusNCT00006055
8Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu ArteritisCompletedNCT01532167
9Carotid Artery Neovascularization in Takayasu's and Giant Cell ArteritisCompletedNCT01795456
10Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
11Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
12Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
13Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
14Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiSCompletedNCT02042092
15Cerebral Perfusion During Neonatal Cardiac SurgeryCompletedNCT01032876
16Determining Disease Activity Biomarkers in Individuals With Takayasu's ArteritisRecruitingNCT00315471
17China Takayasu Arteritis Registry (CTA Registry)RecruitingNCT02964364
18Use of MRI and PET for Assessing Disease Activity in Takayasu's ArteritisRecruitingNCT00744952
19Exercise in Sjogren, Myositis and Takayasu's ArteritisRecruitingNCT01501019
20American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisRecruitingNCT01066208
21Pediatric Vasculitis InitiativeRecruitingNCT02006134
22Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory DiseasesRecruitingNCT02925351
23One-Time DNA Study for VasculitisRecruitingNCT01241305
24VCRC Tissue RepositoryRecruitingNCT02967068
25Vasculitis Pregnancy RegistryRecruitingNCT02593565
26Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence StudyActive, not recruitingNCT01663129
27Evaluation of Panel Reactive Antibody in Children Following Stage I Palliation for Hypoplastic Left Heart SyndromeActive, not recruitingNCT01135485
28VCRC Patient Contact Registry Patient-Reported Data Validation StudyEnrolling by invitationNCT02190942
29Takayasu Arteritis Clinical Trial in ChinaNot yet recruitingNCT02981979
30VCRC Longitudinal Protocol for AortitisNot yet recruitingNCT03022331
31Aortic Arch ReconstructionTerminatedNCT00277940

Search NIH Clinical Center for Takayasu Arteritis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: takayasu arteritis

Genetic Tests for Takayasu Arteritis

About this section

Anatomical Context for Takayasu Arteritis

About this section

MalaCards organs/tissues related to Takayasu Arteritis:

36
Heart, T cells, Skin, Eye, Bone, Thyroid, Endothelial

Publications for Takayasu Arteritis

About this section

Articles related to Takayasu Arteritis:

(show top 50)    (show all 149)
idTitleAuthorsYear
1
Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial. (27771172)
2017
2
Successful treatment of Takayasu arteritis with rituximab as a first-line immunosuppressant. (28073870)
2017
3
Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA. (27832292)
2017
4
Relationship of HLA-B*51 and HLA-B*52 alleles and TNF-I+-308A/G polymorphism with susceptibility to Takayasu arteritis: a meta-analysis. (27815653)
2017
5
An Unusual Association of Chronic Recurrent Multifocal Osteomyelitis, Pyoderma Gangrenosum, and Takayasu Arteritis. (28042129)
2017
6
Takayasu Arteritis with Varied-size Vessel Involvement. (28042128)
2017
7
(18)F]-Sodium fluoride uptake in Takayasu arteritis. (27506703)
2016
8
Early Assessment of Treatment Response in Takayasu Arteritis: An 18FDG PET Procedure. (27280904)
2016
9
Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment. (27567177)
2016
10
Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort. (27908308)
2016
11
Takayasu Arteritis with Multiple Coronary Artery Fistulas to Bronchial Arteries. (28031639)
2016
12
Stroke as the Sole Manifestation of Takayasu Arteritis in a 15-Year-Old Boy with Latent Tuberculosis. (27965905)
2016
13
Posterior reversible encephalopathy syndrome caused by presumed Takayasu arteritis. (28018468)
2016
14
Takayasu arteritis presenting with malignant hypertension; a rare manifestation of a rare disease: a case report and review of the literature. (27216226)
2016
15
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40A years. (27964745)
2016
16
Portal hypertension: an uncommon clinical manifestation of Takayasu arteritis in a 9-year-old child. (27895519)
2016
17
Takayasu arteritis masquerading as stable angina in a 29-year-old man. (27817935)
2016
18
Absence of mycobacterial DNA in peripheral blood and artery specimens in patients with Takayasu arteritis. (27604701)
2016
19
Takayasu arteritis and pregnancy; - a population based study on outcome and mother-child related concerns. (27813289)
2016
20
Coronary artery and supra-aortic vessel revascularization without aortic clamping for Takayasu arteritis. (28011738)
2016
21
Management of a Thoracic Aortic Aneurysm during Pregnancy Leading to the Diagnosis of Takayasu Arteritis. (27395815)
2016
22
Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity. (27989502)
2016
23
Arterial dissection in childhood Takayasu Arteritis: not as rare as thought. (27658465)
2016
24
Reply to recurrent transient ischemic attack as the initial manifestation of Takayasu arteritis. (27261486)
2016
25
An unrecognised presentation of Takayasu arteritis: superficial femoral artery involvement. (27908309)
2016
26
A case of progressive multifocal leukoencephalopathy with Takayasu arteritis and indolent adult T-cell lymphoma/leukemia. (26797479)
2016
27
Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results. (26730842)
2016
28
Recurrent transient ischemic attack as the initial manifestation of Takayasu arteritis. (27261484)
2016
29
Leflunomide in Takayasu arteritis - A long term observational study. (27476631)
2016
30
The role of mean platelet volume in patients with Takayasu arteritis. (27329216)
2016
31
Exercise in takayasu arteritis: Effects on inflammatory and angiogenic factors and disease-related symptoms. (27564917)
2016
32
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. (27531191)
2016
33
Refractory Case of Takayasu Arteritis in a Young Woman: A Clinical Challenge. (27994990)
2016
34
Association of FCGR2A/FCGR3A variant rs2099684 with Takayasu arteritis in the Han Chinese population. (27769046)
2016
35
High Levels of Circulating Endothelial Progenitor Cells are Associated with Acrotism in Patients with Takayasu Arteritis. (27816980)
2016
36
Optical coherence tomography imaging during endovascular treatment of a patient with Takayasu arteritis. (27401294)
2016
37
Similarities between Takayasu arteritis and giant cell arteritis. (27349811)
2016
38
Takayasu arteritis associated with severe renovascular hypertension. (26997400)
2016
39
Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature. (27515155)
2016
40
18F-FDG PET/CT for Detecting Sarcoma of the Aorta in a Patient with Takayasu Arteritis. (27275370)
2016
41
Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis. (24894103)
2016
42
New endovascular techniques for treatment of life-threatening Takayasu arteritis. (27279878)
2016
43
Cause of death in Chinese Takayasu arteritis patients. (27399093)
2016
44
Takayasu Arteritis Presenting as Acute Pericarditis. (27402493)
2016
45
Difficulties in the differential diagnosis between Takayasu arteritis and rheumatic fever: case report. (27267341)
2016
46
Ocular ischemic syndrome and ischemic optic neuropathy in Takayasu arteritis. (25933464)
2015
47
Adalimumab-induced remission of anterior scleritis: a very rare late manifestation of Takayasu arteritis. (26320134)
2015
48
Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. (25931203)
2015
49
HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in the Chinese Han population. (25636572)
2015
50
Acute Inferior Myocardial Infarction as the First Manifestation of Takayasu Arteritis in a Young Boy. (26315096)
2015

Variations for Takayasu Arteritis

About this section

Expression for genes affiliated with Takayasu Arteritis

About this section
Search GEO for disease gene expression data for Takayasu Arteritis.

Pathways for genes affiliated with Takayasu Arteritis

About this section

Pathways related to Takayasu Arteritis according to GeneCards Suite gene sharing:

(show all 41)
idSuper pathwaysScoreTop Affiliating Genes
19.9IL12B, IL6, TNF
29.9IL12B, IL6, TNF
39.6IL6, MMP9, THBD
49.5MMP3, MMP9, SELE
59.5HLA-A, HLA-B, HLA-DPB1, HLA-DRB1
69.3HLA-DPB1, HLA-DRB1, IL12B, IL6, TNF
79.3HLA-DPB1, HLA-DRB1, ICAM1
89.2IL12B, IL2, IL6
99.2ICAM1, TNF, VCAM1
10
Show member pathways
9.2CD40LG, HLA-DPB1, HLA-DRB1, IL12B, TNF
11
Show member pathways
9.2HLA-A, IL2, TNF
129.2ICAM1, SELE, VCAM1
13
Show member pathways
9.1CD40LG, IL2, TNF
149.0ICAM1, IL6, MMP9, TNF
15
Show member pathways
9.0IL12B, IL2, IL6, TNF
16
Show member pathways
9.0HLA-A, HLA-DRB1, IL12B, IL2
178.9IL2, IL6, THBD, TNF
188.9CD40LG, ICAM1, TNF, VCAM1
198.9HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1
208.8HLA-DRB1, IL12B, IL2, IL6, TNF
218.7ICAM1, MMP3, MMP9, VCAM1
228.7CD40LG, IL12B, IL2, IL6, TNF
238.7CD40LG, ICAM1, IL6, TNF, VCAM1
24
Show member pathways
8.6HLA-A, HLA-B, IL12B, IL2, IL6, TNF
258.6HLA-DPB1, HLA-DRB1, ICAM1, IL6, MMP3, TNF
268.6ICAM1, IL12B, IL6, SELE, TNF, VCAM1
278.5ICAM1, IL2, IL6, SELE
28
Show member pathways
8.5HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1, VCAM1
298.5ICAM1, IL6, SELE, THBD, TNF, VCAM1
308.4CD40LG, HLA-A, HLA-B, ICAM1, MICA, VCAM1
318.4CD40LG, ICAM1, IL6, SELE, TNF, VCAM1
32
Show member pathways
8.4CD40LG, HLA-DPB1, HLA-DRB1, IL12B, IL2, TNF
338.2ICAM1, IL2, IL6, MMP9, TNF
348.2ICAM1, IL2, IL6, TNF, VCAM1
35
Show member pathways
8.2HLA-A, HLA-B, ICAM1, IL2, MICA, TNF
368.0ICAM1, IL6, MMP3, MMP9, SELE, TNF
377.9CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1
38
Show member pathways
7.4HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1, IL12B
397.2HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1, IL2
40
Show member pathways
6.9CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1
41
Show member pathways
5.8CD40LG, CRP, HLA-A, HLA-B, HLA-DPB1, HLA-DRB1

GO Terms for genes affiliated with Takayasu Arteritis

About this section

Cellular components related to Takayasu Arteritis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1ER to Golgi transport vesicle membraneGO:001250710.3HLA-A, HLA-B, HLA-DPB1, HLA-DRB1
2MHC class I protein complexGO:004261210.0HLA-A, HLA-B
3integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.7HLA-A, HLA-B, HLA-DPB1, HLA-DRB1
4external side of plasma membraneGO:00098979.4CD40LG, ICAM1, IL6, TNF, VCAM1
5cell surfaceGO:00099868.2CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1
6extracellular regionGO:00055767.9CRP, IL12B, IL2, IL6, MMP3, MMP9
7extracellular spaceGO:00056155.9CD40LG, CRP, ICAM1, IL12B, IL2, IL6

Biological processes related to Takayasu Arteritis according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.8HLA-A, HLA-B
2epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.8IL6, TNF
3defense response to Gram-positive bacteriumGO:005083010.6CRP, IL6, TNF
4antigen processing and presentationGO:001988210.6HLA-A, HLA-B, MICA
5regulation of immunoglobulin secretionGO:005102310.5CD40LG, TNF
6negative regulation of lipid storageGO:001088810.5CRP, IL6, TNF
7cellular response to nutrient levelsGO:003166910.4ICAM1, IL6
8leukocyte tethering or rollingGO:005090110.3SELE, TNF, VCAM1
9membrane to membrane dockingGO:002261410.1ICAM1, VCAM1
10positive regulation of tissue remodelingGO:003410510.1IL12B, IL2
11positive regulation of immunoglobulin secretionGO:005102410.1IL2, IL6
12positive regulation of nitric oxide biosynthetic processGO:004542910.1ICAM1, IL6, TNF
13cellular response to lipopolysaccharideGO:007122210.0ICAM1, IL12B, IL6, TNF
14inflammatory responseGO:00069549.9CD40LG, CRP, IL6, SELE, TNF
15heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesGO:00071579.9ICAM1, SELE, VCAM1
16positive regulation of NF-kappaB transcription factor activityGO:00510929.7CD40LG, ICAM1, IL6, TNF
17positive regulation of interferon-gamma productionGO:00327299.6HLA-DPB1, IL12B, IL2, TNF
18T cell costimulationGO:00312959.6CD40LG, HLA-DPB1, HLA-DRB1
19leukocyte cell-cell adhesionGO:00071599.5CD40LG, ICAM1, SELE, VCAM1
20leukocyte migrationGO:00509009.4ICAM1, MMP9, SELE, THBD, TNF
21response to lipopolysaccharideGO:00324969.2ICAM1, IL6, SELE, THBD, VCAM1
22interferon-gamma-mediated signaling pathwayGO:00603339.2HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, ICAM1, VCAM1
23extracellular matrix organizationGO:00301989.1ICAM1, MMP9, TNF, VCAM1, VWF
24regulation of immune responseGO:00507769.0CD40LG, HLA-A, HLA-B, ICAM1, MICA, VCAM1
25positive regulation of T cell proliferationGO:00421028.8CD40LG, HLA-DPB1, IL12B, IL2, IL6, VCAM1

Molecular functions related to Takayasu Arteritis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1beta-2-microglobulin bindingGO:003088110.6HLA-A, MICA
2peptide antigen bindingGO:00426059.5HLA-A, HLA-B, HLA-DPB1, HLA-DRB1
3cytokine activityGO:00051259.1CD40LG, IL12B, IL2, IL6, TNF

Sources for Takayasu Arteritis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet